Jenson Brooksby accepts provisional ban over missed drug tests, denies charge - NBC Sports
Two-time grand slam champion Simona Halep given four-year ban for doping
Tandon: A closer look at Serena Williams' Therapeutic Use Exemptions
Maria Sharapova's 2-Year Doping Ban Cut To 15 Months : The Two-Way : NPR
Madison Brengle sues WTA and ITF over injuries allegedly caused by doping tests | Tennis | The Guardian
Serena Williams on doping test frequency: 'Discrimination? I think so' | CBC Sports
Simona Halep, Former No. 1 Tennis Player, Suspended for Positive Doping Test - Bloomberg
Serena Williams Says Her Constant Drug Tests Are Discrimination | Teen Vogue
Simona Halep faces 2nd doping charge over biological passport; had failed drug test at US Open | AP News
Tribunal suspected that Halep was blood doping at last year's Wimbledon | Simona Halep | The Guardian
Mikael Ymer banned for 18 months by CAS after missing 3 out-of-competition doping tests - NBC Sports
18 MONTHS. Mikael Ymer suspended for missing 3 doping tests, like Brooksby. - Tennis Tonic - News, Predictions, H2H, Live Scores, stats
Tennis: Sweden's Ymer suspended 18 months for missed doping tests - Omni sports - Sports - Ahram Online
Tennis star Jenson Brooksby accepts provisional ban, but denies doping: 'I've never failed a drug test' | Fox News
/origin-imgresizer.eurosport.com/2018/07/14/2372854-49355850-2560-1440.jpg "Serena Williams: 'Drug test isn't random, it is discrimination' - Eurosport")
Serena Williams: 'Drug test isn't random, it is discrimination' - Eurosport
Star Viktor Troicki says 'treated like a criminal' with doping ban | CNN
Tennis player Simona Halep suspended for doping at U.S. Open | National Post
Jenson Brooksby, an American tennis player, is suspended for 18 months for missing drug tests
Mikael Ymer, world No. 51, banned for 18 months after missing three out-of-competition doping tests
Mikael Ymer banned for 18 months by CAS after missing 3 out-of-competition doping tests - Delta Optimist
The drug Simona Halep tested positive for is part of a new class of blood agents : NPR
